Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Multiple Sclerosis
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Multiple Sclerosis
    TopAbstracts in Multiple Sclerosis 10/29/2009 - (DGNews)
    Experimental Drug Reduces Pseudobulbar Affect in Patients With MS, ALS: Presented at ANA - (DGDispatch)
    TopAbstracts in Multiple Sclerosis 10/15/2009 - (DGNews)
    Glatiramer Acetate Treatment Reduces Risk of Early MS Progressing to Clinically Definite Disease - (DGNews)
    TopAbstracts in Multiple Sclerosis 10/01/2009 - (DGNews)

    News archive

     Recent webcasts/CME - Multiple Sclerosis
    Evidence-Based Update for NPs and PAs in the Diagnosis and Management of Multiple Sclerosis
    Multiple Sclerosis and Managed Care: Evidence-Based Approaches to Optimize Formulary Design and Patient Outcomes

    Webcasts/CME archive

     Recent cases - Multiple Sclerosis
      Encephalomyelitis Mimicking Multiple Sclerosis Associated with Chronic Graft-Versus-Host Disease after Allogeneic Bone Marrow Transplantation
      Progressive Primary Form of Multiple Sclerosis: Clinical and Radiological Improvement with Methylprednisolone in Continuous Pulsetherapy in One Case for 16 Years
      Burrowing of Urinary Bladder Wall by the Tip of a Size 22 Fr Silicone Foley Catheter in an Adult Male Patient With Multiple Sclerosis and Suprapubic Cystostomy: Should Caution be Exercised in Using a Size 22 Fr Silicone Foley Catheter for Long-Term Drainage of Neuropathic Bladder?
      Central Auditory Evaluation in Multiple Sclerosis: Case Report
      Recurrent Acute Hepatitis in Patient Receiving Pulsed Methylprednisolone for Multiple Sclerosis

      Cases archive
        




      my personal edition > multiple sclerosis > news
      divider

        E-Mail this DGReview to a colleague

      DGReview


      Risk of Multiple Sclerosis Exacerbation Doubles Following a Stressful Event

      BMJ

      09/19/2003
      By Joene Hendry


      The risk of increased disease exacerbation is doubled in patients with multiple sclerosis after they experience a non-disease related stressful event, according to the findings of a prospective study of adults with relapsing-remitting multiple sclerosis.

      "The knowledge that stressful events are associated with disease activity adds important information to the limited insight that patients and their caregivers have on this unpredictable disease," writes R. Q. Hintzen, MD, of Erasmus MC, Rotterdam, the Netherlands and colleagues. They analysed the relationship between self reported stressful events and disease exacerbation and infections in 73 patients, aged 18 to 55 years, with relapsing-remitting multiple sclerosis. The patients were mobile (at most required a cane for walking) and had a score of 0 to 6.0 on the expanded disability status scale. The cohort reported at least 2 exacerbations within 24 months prior to inclusion in the study but had no other serious conditions. The cohort's mental health scores were comparable with a group of individuals with relapsing-remitting multiple sclerosis who were not study participants.

      The investigators defined an exacerbation as a worsening of existing symptoms or the appearance of new symptoms lasting more than 24 hours after a minimum of 30 days of improvement or stability. Over an average follow up of 1.4 years, 70 of the 73 participants reported at least one stressful event, as tallied in weekly diaries, for an overall total of 457 events.

      A total of 134 disease exacerbations occurred in 56 patients and a total of 136 episodes of infections occurred in 57 patients, for an average of 1.3 exacerbations or 1.3 infections per year. A Cox univariate regression analysis revealed that the risk of exacerbation was 2.2 times higher during the 4-week period after a stressful event. The risk for a second exacerbation was increased 2.7 times after a 4-week period in which a stressful event occurred.

      Analysis of the increased risk of exacerbations related to infections shows a relative risk of 2.9 for the first exacerbation, 2.7 for the second, and 3.2 for a third exacerbation related to infection. The period of high risk related to infection begins 2 weeks prior to the onset of infection and continues until 5 weeks post infection.

      The investigators note that in this study the patients were regularly evaluated at close intervals, additional evaluations were arranged in cases of infection or exacerbation, and all relapses were confirmed by a physician. Their findings indicate that stress and infection were independently associated with an increased risk of disease exacerbation.

      BMJ 2003;327:646-9.

      E-Mail this DGReview to a colleague   To print, use this version






      All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



      The NTK initiative. Physicians helping physicians identify Need-To-Know science
         Feedback
      Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
      Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
      1
      2
      3
      4
      5
      6
      7
      Send